Peter Radovich Insider Profile
11 Followers
Peter Radovich, Director at MBX Biosciences, Inc., holds ― shares in MBX Biosciences, Inc. (Ticker: MBX), holds 57.26K shares in Mirum Pharmaceuticals (Ticker: MIRM), holds 0.00 shares in Rain Oncology (Ticker: ~RAIN). Most recently, Peter Radovich ― shares of MBX Biosciences, Inc. on ― for an estimated value of ―.
Profitable Transactions
1 out of 11 Profitable Transactions
Average Return
-58.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Peter Radovich holds in companies
Most Profitable Insider Trade
The most profitable trade made by Peter Radovich
Peter Radovich's Trading History
MBX Biosciences, Inc.
―
Director
―
―
Global Blood Therapeutics
Oct 31, 2017
―
Uninformative Sell
437.50K
$604.97K
Mirum Pharmaceuticals
Jun 08, 2026
President & COO
Uninformative Buy
326.00K
$4.87M
Rain Oncology
Jan 26, 2024
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Peter Radovich's performance on stock
You May Also Like
Peter Radovich insider profile FAQ
What is the percentage of profitable transactions made by Peter Radovich?
The percentage of profitable transactions made by Peter Radovich is 9%.
What is the average return per transaction made by Peter Radovich?
The average return per transaction made by Peter Radovich is -58.30%.
What stocks does Peter Radovich hold?
Peter Radovich holds: MBX, GBT, MIRM, ~RAIN stocks.
What was Peter Radovich’s latest transaction?
Peter Radovich latest transaction was an Uninformative Buy of ―.
What was Peter Radovich's most profitable transaction?
Peter Radovich’s most profitable transaction was an Informative Sell of MIRM stock on February 3, 2026. The return on the trade was 23.70%.
What is Peter Radovich's role in MBX Biosciences, Inc.?
Peter Radovich's role in MBX Biosciences, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.